Alpine Immune Sciences, Inc. (ALPN) has a market capitalization of $4.46B and trades at $64.97. The 52-week range is 8.33-65.0.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -101.5, Earnings Per Share (EPS) of $-0.64, annual revenue of $58.88M.
The stock has a beta of 0.97, operates in the Healthcare sector.
